<bill session="116" type="h" number="5497" updated="2020-10-07T18:15:10Z">
  <state datetime="2019-12-19">REFERRED</state>
  <status>
    <introduced datetime="2019-12-19"/>
  </status>
  <introduced datetime="2019-12-19"/>
  <titles>
    <title type="short" as="introduced">Conditional Approval Act</title>
    <title type="short" as="introduced">Conditional Approval Act</title>
    <title type="display">Conditional Approval Act</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited conditional approval pathway, subject to specific obligations, for certain drugs, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="W000821"/>
  <cosponsors>
    <cosponsor bioguide_id="B001309" joined="2019-12-19"/>
    <cosponsor bioguide_id="G000579" joined="2019-12-19"/>
  </cosponsors>
  <actions>
    <action datetime="2019-12-19">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-12-19" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-12-20">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="116" relation="unknown" number="3133"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Civil actions and liability"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health care coverage and access"/>
    <term name="Health information and medical records"/>
    <term name="Marketing and advertising"/>
    <term name="Medical research"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
